C3 Jian Completes Phase 2 Clinical Trial of Anti-Cavity

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
C3 Jian Completes Phase 2 Clinical Trial of Anti-Cavity Drug

LOS ANGELES, Sept. 9, 2014 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on providing improved oral healthcare, announced today that it has successfully completed the initial Phase 2 Clinical Trial for its novel drug, C16G2. The Company's drug targets the specific elimination of Streptococcus mutans , the acid producing bacterium associated with dental caries or tooth decay.

C16G2 is the first peptide therapeutic derived from C3 Jian's proprietary, pheromone signaling platform technology referred to as STAMPs (Specifically Targeted Antimicrobial Peptides). C3 Jian's STAMP technology has the ability to specifically target and kill most types of pathogenic bacteria.    

The Phase 2 clinical trial focused on determining the most effective formulation and mode of application of the drug. The multi-armed, double-blinded, placebo-controlled study compared mouth rinse and gel formulations, with gel applied by manual toothbrush, electric toothbrush and upper and lower dental trays. Efficacy was assessed by measuring the targeted reduction of Streptococcus mutans . Results from this clinical study demonstrated that gel was the preferred formulation. Further, the study showed clear superiority of the C16G2 gel when delivered via custom dental trays. Subjects in the dental tray cohort achieved an average of a 90% reduction of Streptococcus mutans from baseline after one week of treatment. The reductions lasted until the end of the study, or 7 days post treatment. In the combined placebo group, the levels of Streptococcus mutans did not demonstrate the decrease observed in the active treatment groups but increased over baseline levels. Additionally, the study showed an acceptable safety and tolerability profile of the drug.    

"Completing this Phase 2 clinical trial is an exciting and important milestone for C3 Jian. We were able to determine that the amount of time that the drug has in contact with the plaque is important to specifically eliminating S. mutans . We will study this further in our Phase 2b clinical trial that will also explore dose-ranging.  Additionally, we will look at microbiology for longer periods post-treatment to better examine durability of the response," said Todd R. Patrick, C3 Jian's President and CEO. "We are very satisfied that this study shows us that a daily (or nightly) tray treatment or an infrequent treatment protocol, such as a few days a month, will work to specifically reduce S. mutans.  We are quite willing to go to an efficacy study with such a product profile, given that there are already millions of people in the U.S. alone that routinely wear dental trays for a variety or reasons. Further, we see potential product extensions by delivering the drug via toothpaste, varnish and other formats that allow sufficient contact time. So the bottom line is that the results are very encouraging and strongly affirm the direction we are headed with C16G2 and our overall STAMP technology platform."

The indication for C16G2 is the prevention of dental caries in adults, adolescents and pediatrics. According to the U.S. Surgeon General, dental caries, also known as tooth decay or cavities, is rated the most common chronic childhood disease. In the U.S. alone, over $100 billion is spent annually on oral health expenditures covered by insurance. The majority of these expenses are directly related to dental caries.

"These results are extremely encouraging," stated Dr. Wenyuan Shi, Co-Founder/Chief Scientific Officer of C3 Jian and Chairman of Oral Biology at the University of California, Los Angeles (UCLA). "Our initial idea of formulating the drug into a mouth rinse really didn't show any long term effect on Streptococcus mutans . Seeing the results of the drug in a gel, delivered by a manual toothbrush and especially in a dental tray are very impressive. To see notable and specific reductions of Streptococcus mutans seven days after ending all treatment is exciting. It would appear we have modified the microbiome, which may lead to long lasting protection beyond the treatment window. We are looking ahead to subsequent clinical testing to further demonstrate this effect."   

About C3 Jian, Inc.

C3 Jian is a clinical-stage biotechnology company developing and commercializing novel products to diagnose, treat and prevent diseases related to the human microbiome, with an initial focus on improving oral health. C3 is advancing proprietary targeted solutions, which can offer more selective, efficacious and safer treatment modalities than broad spectrum antibiotics. The Company's platform cell signaling STAMP technology has potential applications to a variety of diseases and disorders particularly related to bacterial and fungal infections. C3 Jian is based in Los Angeles, California. For more information about the company, please visit www.c3-jian.com .

CONTACT: Media Contact: Mr. Justin Hsiao, (T) 310.665.2928 x206, Email: jhsiao@c3-jian.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sandals Foundation: Win a Trip, Boost Caribbean Education

Updated Category News Views 6

Sandals Resorts Stakes a Claim in Education While the rest of us are gravitating towards Black Friday deals and Cyber Monday sales, the Sandals Foundation decided to play a different game. This Giving Tuesday, they invite travelers not just to soak in the sun, but to spread a little of it around by supporting education for kids across the Caribbean. It's a classic example...

Continue Reading
Tammy Keller's Devotional Guides Living with Purpose

Updated Category News Views 138

Finding Meaning in the Dash of Life Life isn’t just bookended by birth and death; it’s the dash in between that counts. If you were sitting next to Tammy Keller right now, you’d probably hear that heartfelt truth straight from her. Her new work, "Your--Dash Devotional," rattles the soul by offering a profound look at making every moment intentional, vivid, and...

Continue Reading
Chicago Auto Show: Run & Explore Indoors This February

Updated Category News Views 41

Nobody’s thinking about running laps when they walk into a colossal auto show, but the Chicago Auto Show isn't letting the pedal ease off the gas. Swing by on February 14, folks, for something not typically seen on the floors of McCormick Place. Run participants have got one hour to log as many miles as they can on the 2.4-mile loop right inside the show. Why a Running...

Continue Reading
Galileo's Robot Dog Takes Charge in Polish Warehouses

Updated Category News Views 179

Robotic Innovation Makes Waves in Europe You ever think you’d see the day when a dog—albeit a robotic one—takes the night shift at a warehouse? Well, here we are. Galileo Robotics has unleashed its C1-W robot dog in Poznan, Poland, and it's more than just a fancy tech gimmick. This thing's got potential, bridging gaps left wide open by human labor shortages and...

Continue Reading
Armada Moves up as Key Player in US SI Exports

Updated Category News Views 61

Pioneering New Grounds in Intelligence Infrastructure Hell of a move by Armada, stepping into the limelight as a priority team leader in the U.S. SI Exports Program. The whole gig is under the Department of Commerce's belt, pushing the frontier of America's Super Intelligence (SI) technology to buddies across the globe. It's like watching the next big blockbuster unfold...

Continue Reading
Neil deGrasse Tyson Headlines HIMSS27 with Cosmic Insights

Updated Category News Views 153

celebrated science communicator, is set to close out the HIMSS27 conference with a keynote that's bound to leave a lasting impression. It's a fitting intersection of stars and stethoscopes, as the astrophysicist brings his expansive lens to the nitty-gritty of healthcare innovation. Splicing Science with Storytelling Folks, this ain't your standard healthcare gathering....

Continue Reading
Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 114

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Sasol AGM Resolutions Passed in One Swift Swing

Updated Category News Views 192

Sasol's AGM Delivers Smooth Sailing for Shareholders Can't say I'm surprised, but Sasol's annual general meeting on the 13th of November went off without a hitch—unless, of course, you're one of those folks who just loves fireworks at these gatherings. The entire set of resolutions danced through with a resounding "Aye," making it one heck of a day for anyone banking on...

Continue Reading
Stellus PBDC's Q3: Solid Income but NAV Drops

Updated Category News Views 56

Stellus PBDC: Q3 Earnings and Strategic Moves Things are getting interesting in Houston where Stellus Private Credit BDC just laid out its financial cards for the third quarter of 2026. Now, I’ve seen my fair share of quarterly reports, but Stellus seems to have stitched a quilt of mixed results this time around. Investment Income and Portfolio Shifts First off, net...

Continue Reading
ZTE Reinvents Energy for AI Data Centers

Updated Category News Views 200

The Great Race: Power and AI in Sync Here we are, neck-deep in the AI era, where the demand for raw computing power just won’t quit. With every data-hungry application and supercharged algorithm, companies are scrambling to keep up. But there’s a nasty little dragon in this fairy tale—energy efficiency. ZTE isn’t just acknowledging this beast; they’re ready to...

Continue Reading

Top 5 Most Recently Viewed Articles

Analyzing Market Dynamics: Dollar Strength and Economic Trends

Updated Category News Views 280

Understanding Current Market Trends In today's financial landscape, the dollar has been showing significant strength, propelled largely by the increasing yields of U.S. Treasuries. This upswing marks the dollar reaching levels not seen in nearly three months against both the euro and the yen, signaling contrasting economic conditions across these regions. Economic...

Continue Reading
Bitcoin Surpasses $99K: Insights on Market Movements

Updated Category News Views 245

Bitcoin's Impressive Recovery Journey Bitcoin has displayed remarkable resilience in the market, experiencing gains for the seventh consecutive day with its price hitting $99,513.7. This uptrend comes after a challenging year-end period that saw a significant dip in value. As investors closely monitor the evolving regulatory outlook in the United States under the...

Continue Reading
StoneX Group Inc. Prepares for First Quarter Earnings Release

Updated Category News Views 102

StoneX Group Inc. Prepares for Earnings Release StoneX Group Inc. (NASDAQ: SNEX) is gearing up to share its fiscal 2025 first quarter financial results. This release is scheduled for a date soon to come, creating excitement within the investment community. As a part of its commitment to transparency and investor engagement, the company will host a conference call the...

Continue Reading
Down4Sound Introduces High-Power DVX Subwoofer Series

Updated Category News Views 82

Down4Sound Launches Exciting New DVX Subwoofer Series Down4Sound, a renowned name in high-performance car audio systems, has announced the introduction of their groundbreaking DVX Subwoofer Series. This innovative product line promises to redefine audio experiences for enthusiasts everywhere, boasting a phenomenal 1700W RMS power output across multiple size options to...

Continue Reading
Jozu Boosts AI Deployment Speed and Strengthens Security Efforts

Updated Category News Views 365

Accelerating AI Deployment with Jozu Jozu has unveiled an innovative enterprise AI orchestration platform that significantly reduces the time required for deploying AI applications while enhancing security and compliance protocols. This platform addresses the increasing demands faced by organizations in managing AI applications effectively. Enhancing AI Management Across...

Continue Reading